We are building a stronger Business Community in Flemingsberg

We are actively collaborating with key stakeholders to strengthen the innovation ecosystem and promote entrepreneurship in Flemingsberg. A central part of our efforts involves being present alongside other important actors and creating meeting spaces to build close relationships with those who work in the area on a daily basis. We believe that exciting and new opportunities emerge when people come together and exchange ideas.

As part of our Business Community, we recently had the pleasure of inviting Business Sweden to present their latest report, “THE ROAD TO PERSONALISED MEDICINE.” The report highlights the transition to digital health and precision medicine across various markets and emphasizes the business opportunities this development could offer Swedish healthcare companies in Europe. See the interview below with Louise Bengtsson, Senior Consultant at Business Sweden.

Stay updated and sign up for upcoming community events here.

HackNation Comes to Flemingsberg: Strengthening the Connection Between Stockholm and Silicon Valley

A global innovation network with roots in MIT and Silicon Valley is coming to Flemingsberg. On October 3-4, students, researchers, entrepreneurs and developers will gather at Innovation Station to build solutions alongside participants from more than 65 countries. The initiative is led by the GameTech initiative Press Start and the life science initiative Life Science Cluster Flemingsberg, with the ambition of creating new bridges between Stockholm, Silicon Valley and some of the world's leading innovation ecosystems.

Building a heart: Realheart aims to create new opportunities for patients with heart failure

A mechanical heart, as close to a human heart as it gets. Realheart is the company developing a total artificial heart for patients with advanced heart failure, a condition where treatment options are often limited. When we sit down with CEO Ina Laura Perkins, she tells the story of an innovation that has taken its time, about the strong drive to reach all the way to patients, and about steps that are bringing the company closer to clinical reality.

Go to Top